<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02841826</url>
  </required_header>
  <id_info>
    <org_study_id>PIUD</org_study_id>
    <nct_id>NCT02841826</nct_id>
  </id_info>
  <brief_title>Evaluation of a Novel and Simplified Technique for Intrauterine Contraceptive Devices Insertion: a Prospective Cohort Study</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The intrauterine devices (IUDs) are a safe, reliable, long-acting and reversible
      contraceptive method. It is also sound safe and cheap contraceptive methods available and is
      nearly maintenance free for up to 10 years.

      The fear and the pain associated with IUDs insertion consider barriers to using this
      contraception method, this is because that the mucosal lining of female genital tract is
      highly sensitive to touch and pain. However; most of small procedures done in this sensitive
      area are performed without analgesia.

      The pain during IUDs insertion is due to application of the tenaculum , traction of the
      cervical canal, passing the uterine sound, insertion of the IUDs through the cervix, and
      irritation of the endometrial lining by the IUDs.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Actual">July 2016</completion_date>
  <primary_completion_date type="Actual">July 2016</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The degree of pain perception measured visual analogue score</measure>
    <time_frame>15 minutes</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Contraception</condition>
  <arm_group>
    <arm_group_label>Group I: IUD without uterine sound group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Transvaginal ultrasound before to intrauterine contraceptive device insertion without uterine sounding.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group II: IUD with uterine sound</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Intrauterine contraceptive device inserted by classic method</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>IUD</intervention_name>
    <arm_group_label>Group I: IUD without uterine sound group</arm_group_label>
    <arm_group_label>Group II: IUD with uterine sound</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Uterine sounding</intervention_name>
    <arm_group_label>Group II: IUD with uterine sound</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Transvaginal ultrasound</intervention_name>
    <arm_group_label>Group I: IUD without uterine sound group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women requesting intrauterine contraceptive device as a contraction

          -  Women accepted participation in the study

        Exclusion Criteria:

          -  Uterine abnormalities

          -  Endometrial lesions as polyp

          -  Adenomyosis

          -  Fibroids distorting the cavity

          -  Intrauterine adhesions.

          -  Chronic pelvic pain

          -  Dysmenorrhea

          -  History of cervical surgery
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Women Health Hospital - Assiut university</name>
      <address>
        <city>Assiut</city>
        <zip>71111</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 20, 2016</study_first_submitted>
  <study_first_submitted_qc>July 20, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 22, 2016</study_first_posted>
  <last_update_submitted>November 23, 2016</last_update_submitted>
  <last_update_submitted_qc>November 23, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 25, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Mohammed Khairy Ali</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Contraceptive Agents</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

